{"date":"2026-02-04","count":7,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4174-2026-02-04-1755-w4kw2b","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-02-04","time":"17:55:33","subject":"本公司接獲美國西南腫瘤集團通知，關於其主導OBI-3424之T細胞急性淋巴性白血病（T-ALL）及T細胞淋巴母細胞淋巴瘤(T-LBL)二期臨床試驗第一階段初步分析結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-02-04 17:55，「本公司接獲美國西南腫瘤集團通知，關於其主導OBI-3424之T細胞急性淋巴性白血病（T-ALL）及T細胞淋巴母細胞淋巴瘤」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-04-1715-f7zdi0","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-04","time":"17:15:37","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-04 17:15，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-02-04-1653-1hv46vb","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-02-04","time":"16:53:16","subject":"公告本公司決議向金融監督管理委員會申請撤銷114年第1次現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-02-04 16:53，「公告本公司決議向金融監督管理委員會申請撤銷114年第1次現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-02-04-1613-1njncgj","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-02-04","time":"16:13:29","subject":"公告本公司最近一年累積取得有價證券達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-02-04 16:13，「公告本公司最近一年累積取得有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-02-04-1607-j432qn","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-02-04","time":"16:07:13","subject":"本公司董事會通過簽訂獨家授權經銷協議(補充114/12/26重訊)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-02-04 16:07，「本公司董事會通過簽訂獨家授權經銷協議(補充114/12/26重訊)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-02-04-1356-bmrnhn","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-02-04","time":"13:56:28","subject":"公告本公司董事會決議召開一一五年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-02-04 13:56，「公告本公司董事會決議召開一一五年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-02-04-1352-isqttc","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-02-04","time":"13:52:42","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-02-04 13:52，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}